AIM ImmunoTech (AIM) Invested Capital (2011 - 2021)
AIM ImmunoTech's (AIM) quarterly Invested Capital came in at $234000.0 in Q1 2021, up 7.83% YoY from $217000.0 in Q1 2020, and up 1.74% on a QoQ basis from $230000.0 in Q4 2020.
AIM ImmunoTech (AIM) Invested Capital (2011 - 2021) Analysis & Trends
AIM ImmunoTech (AIM) has 7 years of Invested Capital data on file, last reported at $234000.0 in Q1 2021.
- Quarterly Invested Capital rose 7.83% year-over-year to $234000.0 in Q1 2021, while the trailing twelve-month figure through Dec 2021 was $234000.0 (down 73.83% YoY) and the FY2020 annual result came in at $230000.0, up 7.48% from the prior year.
- Invested Capital advanced to $234000.0 in Q1 2021, from $230000.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $234000.0 in Q1 2021 to a low of $195000.0 in Q2 2018.
- A 4-year average of $213153.8 and a median of $214000.0 in 2019 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2019 — Invested Capital declined 9.46% — and 2020, when it gained 7.96%.
- Tracing AIM's Invested Capital over 4 years: stood at $199000.0 in 2018, then increased by 7.54% to $214000.0 in 2019, then grew by 7.48% to $230000.0 in 2020, then rose by 1.74% to $234000.0 in 2021.
- The last three Invested Capital figures came in at $234000.0 (Q1 2021), $230000.0 (Q4 2020), and $226000.0 (Q3 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | AIM ImmunoTech | 4.43 Mn | -5.53 Mn | 21,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 234,000.00 |
| Dec 31, 2020 | 230,000.00 |
| Sep 30, 2020 | 226,000.00 |
| Jun 30, 2020 | 221,000.00 |
| Mar 31, 2020 | 217,000.00 |
| Dec 31, 2019 | 214,000.00 |
| Sep 30, 2019 | 210,000.00 |
| Jun 30, 2019 | 205,000.00 |
| Mar 31, 2019 | 201,000.00 |
| Dec 31, 2018 | 199,000.00 |
| Sep 30, 2018 | 197,000.00 |
| Jun 30, 2018 | 195,000.00 |
| Mar 31, 2018 | 222,000.00 |
| Sep 30, 2013 | 7.05 Mn |
| Jun 30, 2013 | 7.05 Mn |
| Mar 31, 2013 | 7.05 Mn |
| Dec 31, 2012 | 7.05 Mn |
| Sep 30, 2012 | 5.76 Mn |
| Jun 30, 2012 | 4.34 Mn |
| Mar 31, 2012 | 2.28 Mn |